Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 37.82 CNY 0.45%
Market Cap: 34.9B CNY
Have any thoughts about
Livzon Pharmaceutical Group Inc?
Write Note

EV/S
Enterprise Value to Sales

2.3
Current
2.2
Median
2.7
Industry
Higher than median
Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
2.3
=
Enterprise Value
26.9B CNY
/
Revenue
11.9B CNY
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
2.1
2-Years Forward
EV/S
2
3-Years Forward
EV/S
1.9

See Also

Discover More